Difference between revisions of "Part:BBa K5302023"

Revision as of 11:02, 1 October 2024

This work is derived from pBBRMCS-OmpA-mCherry and PUC19-ZVEGF-V114-V107-peptide, and it has undergone codon optimization. This composite part combines OmpA(21.4kda) and V107(approximately 2kda), we succeeded in transferring this plasmid into Escherichia coli Nissle 1917 and let it express V107. The plasmid uses lac promotor and has kanamycin resistence.

Revision as of 07:48, 1 October 2024 (view source) Registry (Talk \| contribs)	Revision as of 11:02, 1 October 2024 (view source) Xiaotian (Talk \| contribs) Newer edit →
Line 1:	Line 1:
−	+	This work is derived from pBBRMCS-OmpA-mCherry and PUC19-ZVEGF-V114-V107-peptide, and it has undergone codon optimization. This composite part combines OmpA(21.4kda) and V107(approximately 2kda), we succeeded in transferring this plasmid into Escherichia coli Nissle 1917 and let it express V107. The plasmid uses lac promotor and has kanamycin resistence.